Article info
PDFClinical science
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial
- Correspondence to Timothy L Jackson, Ophthalmology, King's College London Faculty of Life Sciences and Medicine, London, London, UK; t.jackson1{at}nhs.net
Citation
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial
Publication history
- Received October 12, 2021
- Accepted January 17, 2022
- First published February 25, 2022.
Online issue publication
June 22, 2023
Article Versions
- Previous version (25 February 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.